CHURCHILL MANAGEMENT Corp Acquires Shares of 18,392 Hims & Hers Health, Inc. (NYSE:HIMS)

CHURCHILL MANAGEMENT Corp bought a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 18,392 shares of the company's stock, valued at approximately $445,000.

Other hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC lifted its stake in Hims & Hers Health by 2,173.7% in the 4th quarter. GAMMA Investing LLC now owns 2,251 shares of the company's stock worth $54,000 after acquiring an additional 2,152 shares in the last quarter. Quest Partners LLC lifted its position in shares of Hims & Hers Health by 22.6% in the third quarter. Quest Partners LLC now owns 4,373 shares of the company's stock worth $81,000 after purchasing an additional 807 shares in the last quarter. CWM LLC boosted its holdings in shares of Hims & Hers Health by 21.4% during the third quarter. CWM LLC now owns 5,982 shares of the company's stock worth $110,000 after purchasing an additional 1,054 shares during the period. Quarry LP grew its position in Hims & Hers Health by 91.0% during the third quarter. Quarry LP now owns 6,113 shares of the company's stock valued at $113,000 after purchasing an additional 2,913 shares in the last quarter. Finally, Amalgamated Bank increased its stake in Hims & Hers Health by 55.9% in the 2nd quarter. Amalgamated Bank now owns 6,566 shares of the company's stock valued at $133,000 after buying an additional 2,354 shares during the period. Institutional investors and hedge funds own 63.52% of the company's stock.

Hims & Hers Health Stock Down 0.5 %

Hims & Hers Health stock traded down $0.14 during trading hours on Friday, hitting $27.80. The stock had a trading volume of 18,842,443 shares, compared to its average volume of 10,492,087. The company has a 50-day moving average of $27.60 and a two-hundred day moving average of $21.80. Hims & Hers Health, Inc. has a fifty-two week low of $8.14 and a fifty-two week high of $35.02. The company has a market cap of $6.07 billion, a PE ratio of 63.19 and a beta of 1.31.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.32 EPS for the quarter, beating analysts' consensus estimates of $0.06 by $0.26. Hims & Hers Health had a return on equity of 10.97% and a net margin of 8.19%. The business had revenue of $401.56 million during the quarter, compared to analyst estimates of $382.20 million. During the same period in the prior year, the company posted ($0.04) earnings per share. Hims & Hers Health's revenue was up 77.1% on a year-over-year basis. As a group, analysts forecast that Hims & Hers Health, Inc. will post 0.29 EPS for the current fiscal year.

Analysts Set New Price Targets

HIMS has been the subject of a number of research reports. Morgan Stanley began coverage on shares of Hims & Hers Health in a research note on Tuesday, December 17th. They set an "overweight" rating and a $42.00 target price for the company. Needham & Company LLC increased their price objective on Hims & Hers Health from $28.00 to $31.00 and gave the stock a "buy" rating in a report on Monday, January 6th. Bank of America downgraded shares of Hims & Hers Health from a "buy" rating to an "underperform" rating and decreased their target price for the stock from $32.00 to $18.00 in a research report on Thursday, November 14th. TD Cowen restated a "buy" rating and set a $28.00 price target on shares of Hims & Hers Health in a report on Wednesday, November 20th. Finally, Canaccord Genuity Group upped their price objective on shares of Hims & Hers Health from $28.00 to $38.00 and gave the stock a "buy" rating in a report on Monday, December 2nd. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Hims & Hers Health currently has a consensus rating of "Hold" and a consensus target price of $25.13.

Insider Activity at Hims & Hers Health

In related news, insider Michael Chi sold 7,259 shares of the business's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $24.07, for a total value of $174,724.13. Following the sale, the insider now owns 193,601 shares of the company's stock, valued at $4,659,976.07. The trade was a 3.61 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Patrick Harrison Carroll sold 15,000 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $22.07, for a total value of $331,050.00. Following the transaction, the insider now owns 196,941 shares of the company's stock, valued at $4,346,487.87. This represents a 7.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 1,080,208 shares of company stock valued at $29,106,823 over the last quarter. 17.71% of the stock is owned by company insiders.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.